knee osteoarthritis, other
Conditions
Interventions
None listed
Sponsors
Stryker Japan K.K.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patient is a candidate for knee arthroplasty with Mako, or patient underwent knee arthroplasty with Mako. 2) Patient has signed an Informed Patient Consent Form*. 3) Patient expects to be evaluable for 2-years observation period postoperatively*. *Not applicable for patients included with opt-out.
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effectiveness Revision rate due to poor implant placement up to 2 years postoperatively | — |
Secondary
| Measure | Time frame |
|---|---|
| Effectiveness -accuracy of Implant placement - Improvement of postoperative knee function (patient-based outcomes such as KSS, JOA score, FJS, etc.) - reduction of early postoperative pain (VAS score, painkillers usage) Safety incidence of intraoperative complications | — |
Countries
Japan
Contacts
Public ContactKenta Suzuki
Stryker Japan K.K. Clinical Affairs
Outcome results
None listed